Table 3.

Insulin BBB pharmacokinetics in the absence of serum factors following chronic rapamycin treatment based on Figure 8.

Sex	Treatment	Ki (µL/g∙min)	Ki p-Value	r	Vi (µL/g)	Vi p-Value
Male	Vehicle	1.32 ± 0.42	0.97	0.766	9.6 ± 1.3	0.122
	Rapamycin	1.35 ± 0.53		0.672	8.0 ± 1.7
Female	Vehicle	0.90 ± 0.83 (ns)	0.35	0.378	11.5 ± 2.7	0.860
	Rapamycin	1.89 ± 0.63		0.726	8.3 ± 2.1